Abstract:Peroxiredoxin-I is a protein encoded by the Peroxiredoxin I gene, which highly expressed in many tumor tissues, such as lung cancer, breast cancer, rectal cancer, stomach cancer. Peroxiredoxin-I has a proliferative effect and plays a role in cancer development, recurrence or progression. The mAb 109 antibody can specific binding to Peroxiredoxin-I protein. We recently reported the synthesis Tc-99m-labeled mAb109 for Single-photon emission computed tomography (SPECT) imaging. Those studies have showed that Tc-99m-mAb 109 still preserved its biological functions and specifically binding to the target tumors. The aim of this research was to develop new radionuclide labeled mAb109 antibody for prolonged tumor targeted molecular imaging. In this paper, the precursor compound 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane1,4,7,10-tetraacetic acid-mAb 109 (DOTA-mAb109) was synthesized for potential radioactive imaging agents. Then, a radioisotope indium-111 (t(1/2)= 67.3 h) was labeling to DOTA-mAb109 for further radio-biological evaluation. The DOTA is chelated to the In-111(3+) center through four nitrogens and four carboxylate oxygens, resulting in an eight-coordinate complex. The labeling efficiency of In-111-DOTA-mAb109 was tested by Radio-TLC/HPLC. The radiolabeling yield was over 96%, the radio chemical purity was over 99% by PD-10 column purification. The in vitro stability tests were presented in 5% Human serum albumin (HSA) for 72 h at 25 degrees C Less than 5% In-111 dissociation was detected by Radio-HPLC. In-111-DOTA-mAb109 shows excellent radiochemical property. Nano-SPECT imaging of pancreatic carcinoma-1 tumor-bearing nude mice revealed that tumor uptake of In-111-DOTA-mAb109 got a gradual accumulation from 24 h, 48 h to 72 h after post-injection of 18.5 MBq radiolabeled antibody. The cardiac area was clearly seen up to 48 h post injection, reflecting a long blood circulation time for In-111-DOTA-mAb109. Uptake in the tumor was clearly visualized by emission computed tomography. These results suggest that the In-111-DOTA-mAb109 molecular probe is a promising tracer for tumor diagnosis.

Synthesis and Biological Evaluation of Tc-99m(Co)(3)(Ida-Cpt) for Tumor Imaging

Synthesis And Biodistribution Of Novel Tc-99m Labeled 4-Nitroimidazole Dithiocarbamate Complexes As Potential Agents To Target Tumor Hypoxia

Synthesis and Biodistribution of the 99m Tc Nitrido Complex with 2-(4-nitro-1h-imidazolyl)ethyl Dithiocarbamate (NIET)

[Tc-99M(co)(3)](+) Labeled Histidine Derivative Containing 4-Nitroimidazole: Synthesis, Biodistribution As A Tumor Hypoxia Imaging Agent

Synthesis and Biological Evaluation of a Novel 99mtc Cyclopentadienyl Tricarbonyl Complex ([(Cp-R)99mtc(co)3]) for Sigma-2 Receptor Tumor Imaging

Synthesis and Biological Studies of 99m Tc(HYNIC–MFL)(tricine)(TPPTS) As a Novel Tumor Imaging Agent

Preparation and Biological Evaluation of 99Mtc-N4ipa for Single Photon Emission Computerized Tomography Imaging of Hypoxia in Mouse Tumor

99m Tc-labeled colchicine for tumor imaging using DTPA as bifunctional chelating agent

Preparation and Biological Evaluation of 111In-Triphenylphosphonium Cations

Synthesis and biodistribution of 99Tcm-Cetuximab antibody for lung tumor targeted molecular imaging

Preparation and Evaluation of Tc-99m-Labeled Dimeric Tyr(3)-Octreotide in the Ar42j Tumor Model

Synthesis and Biological Results of the Technetium-99M-labeled 4-Nitroimidazole for Imaging Tumor Hypoxia

Synthesis and Radiolabeling of (111)In-Core-cross Linked Polymeric Micelle-Octreotide for Near-Infrared Fluoroscopy and Single Photon Emission Computed Tomography Imaging.

Design and Bio.Evaluation of Cu-64-Nota-Herceptin for Tumor Targeted Micro-Pet Imaging

Synthesis and Evaluation Of111in-Dota-mab109 Monoclonal Antibody for Potential SPECT Molecular Imaging

A thiourea‐bridged 99mTc(CO)3‐dipicolylamine‐2‐nitroimidazole complex for targeting tumor hypoxia: Utilizing metabolizable thiourea‐bridge to improve pharmacokinetics

(99M)tc-Labeled Dimeric Octreotide Peptide: a Radiotracer with High Tumor Uptake for Single-Photon Emission Computed Tomography Imaging of Somatostatin Receptor Subtype 2-Positive Tumors.

<sup>99m</sup>Tc-Labeled Bombesin(7−14)NH<sub>2</sub>with Favorable Properties for SPECT Imaging of Colon Cancer

Tc-99m-Labeled Bombesin(7-14)Nh2 With Favorable Properties For Spect Imaging Of Colon Cancer

Preparation and biodistribution of a (99m)Tc tricarbonyl complex with deoxyglucose dithiocarbamate as a tumor imaging agent for SPECT.

99Tcmn-Dgdtc,a New Glucose Metabolic Agent,the Pharmacokinetics and Imaging Results